Investigating how a specific stress response affects pain in diabetes
Targeting methylglyoxal-induced diabetic neuropathic pain through the integrated stress response
This study is looking at how a substance called methylglyoxal, which is produced when your body makes energy, might be causing extra pain for people with diabetes, and it hopes to find new ways to help ease that pain and improve daily life for those affected.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Dallas NIH-funded |
| Lab location | 1 site (Richardson, United States) |
| Project ID | NIH-10923791 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of methylglyoxal, a by-product of energy production, in causing chronic pain associated with diabetes. It explores how this compound triggers a stress response in nerve cells, leading to increased pain sensitivity. By studying both animal models and human sensory neurons, the research aims to identify potential therapeutic targets to alleviate diabetic neuropathic pain. The ultimate goal is to develop new treatment strategies that can improve the quality of life for individuals suffering from this condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with diabetes who experience chronic neuropathic pain.
Not a fit: Patients without diabetes or those who do not experience neuropathic pain may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly reduce chronic pain in diabetic patients.
How similar studies have performed: Previous research has shown promising results in targeting stress responses for pain management, suggesting potential success for this approach.
Where this research is happening
Richardson, United States
- University of Texas Dallas — Richardson, United States (Active)
Researchers
- Principal investigator: Yousuf, Muhammad Saad — University of Texas Dallas
- Study coordinator: Yousuf, Muhammad Saad
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.